US4390531A
(en)
*
|
1981-08-10 |
1983-06-28 |
Syntex Pharmaceuticals International Ltd. |
Method of contraception using peak progestogen dosage
|
US4961931A
(en)
*
|
1982-07-29 |
1990-10-09 |
Alza Corporation |
Method for the management of hyperplasia
|
AU582540B2
(en)
*
|
1983-08-05 |
1989-04-06 |
Pre Jay Holdings Ltd. |
A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
|
US4826831A
(en)
*
|
1983-08-05 |
1989-05-02 |
Pre Jay Holdings Limited |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
|
US5010070A
(en)
*
|
1987-06-15 |
1991-04-23 |
Warner-Lambert Company |
Graduated estrogen contraceptive
|
US4962098A
(en)
*
|
1987-06-15 |
1990-10-09 |
Warner-Lambert Company |
Graduated estrogen contraceptive
|
US4816257A
(en)
*
|
1985-09-20 |
1989-03-28 |
Research & Education Institute, Harbor-Ucla Medical Center Inc. |
Method for producing an in vivo environment suitable for human embryo transfer
|
US5208225A
(en)
*
|
1986-02-27 |
1993-05-04 |
Warner-Lambert Company |
Compositions containing fixed combinations
|
SE8602666D0
(sv)
*
|
1986-06-16 |
1986-06-16 |
Leo Ab |
Intravaginal devices
|
DK174724B1
(da)
*
|
1986-07-15 |
2003-10-06 |
Wyeth Corp |
Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
|
US4855305A
(en)
*
|
1987-03-23 |
1989-08-08 |
Applied Medical Research |
Compositions and methods of effecting contraception utilizing melatonin
|
US4900734A
(en)
*
|
1987-08-27 |
1990-02-13 |
Maxson Wayne S |
Novel pharmaceutical composition containing estradiol and progesterone for oral administration
|
NZ226316A
(en)
*
|
1987-09-24 |
1991-10-25 |
Jencap Research Ltd |
Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance
|
US5276022A
(en)
*
|
1987-09-24 |
1994-01-04 |
Jencap Research Ltd. |
Hormone preparation and method
|
US5108995A
(en)
*
|
1987-09-24 |
1992-04-28 |
Jencap Research Ltd. |
Hormone preparation and method
|
HUT52382A
(en)
*
|
1988-03-14 |
1990-07-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
|
US5043331A
(en)
*
|
1989-06-15 |
1991-08-27 |
Orion-Yhtyma Oy |
Treatment of postmenopausal disorders
|
US5783571A
(en)
*
|
1991-01-07 |
1998-07-21 |
Pherin Corporation |
Method of altering hypothalamic function by nasal administration of estrene steroids
|
US5925774A
(en)
*
|
1991-01-07 |
1999-07-20 |
Pherin Corporation |
Estrenes for inducing hypothalamic effects
|
US5969168A
(en)
*
|
1991-01-07 |
1999-10-19 |
Pherin Corporation |
Androstanes for inducing hypothalamic effects
|
US5883087A
(en)
*
|
1991-01-07 |
1999-03-16 |
Pherin Corporation |
Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
|
DE69433994T2
(de)
*
|
1993-01-19 |
2005-09-22 |
Endorecherche Inc., Ste-Foy |
Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
|
US5776923A
(en)
*
|
1993-01-19 |
1998-07-07 |
Endorecherche, Inc. |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
|
AU693077B2
(en)
*
|
1993-06-15 |
1998-06-25 |
Pherin Pharmaceuticals, Inc. |
Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
|
US5591753A
(en)
*
|
1994-01-28 |
1997-01-07 |
Eli Lilly And Company |
Combination treatment for osteoporosis
|
DE4429374C1
(de)
|
1994-08-12 |
1996-02-01 |
Jenapharm Gmbh |
Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
|
US5759577A
(en)
*
|
1995-01-17 |
1998-06-02 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5547948A
(en)
*
|
1995-01-17 |
1996-08-20 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
US5994329A
(en)
|
1997-07-22 |
1999-11-30 |
Merck & Co., Inc. |
Method for inhibiting bone resorption
|
US6432932B1
(en)
|
1997-07-22 |
2002-08-13 |
Merck & Co., Inc. |
Method for inhibiting bone resorption
|
US6703367B1
(en)
|
1999-04-27 |
2004-03-09 |
Praecis Pharmaceuticals Inc. |
Methods for treating hot flashes and gynaecomastia
|
AU2580001A
(en)
|
1999-12-20 |
2001-07-03 |
Merck & Co., Inc. |
Blister package for pharmaceutical treatment card
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US6660726B2
(en)
*
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US20030004145A1
(en)
|
2001-05-16 |
2003-01-02 |
Leonard Thomas W. |
Treatment of conditions relating to hormone deficiencies by administration of progestins
|
JP2005531532A
(ja)
*
|
2002-04-05 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
アレンドロナートおよびビタミンd製剤を用いる骨吸収阻害法
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
WO2004091535A2
(fr)
*
|
2003-04-11 |
2004-10-28 |
Barr Laboratories, Inc. |
Procede d'administration d'oestrogenes et de progestatifs
|
US20050261250A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Merck & Co., Inc., |
Compositions and methods for inhibiting bone resorption
|
US7623924B2
(en)
*
|
2004-08-31 |
2009-11-24 |
Leptos Biomedical, Inc. |
Devices and methods for gynecologic hormone modulation in mammals
|
CA2601773A1
(fr)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
|
UY33103A
(es)
|
2009-12-15 |
2011-07-29 |
Techsphere S A De C V |
Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
|